R. T. Skrinak

发表

GPNMB confers risk for Parkinson’s disease through interaction with α-synuclein

D. Weintraub, K. Luk, V. V. Van Deerlin, 2022, Science.

Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's Disease

J. Trojanowski, D. Weintraub, S. Xie, 2022, medRxiv.

Characterization of Parkinson’s disease using blood-based biomarkers: A multicohort proteomic analysis

J. Trojanowski, Xuemei Huang, A. Siderowf, 2019, PLoS medicine.

Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes.

A. Chen-Plotkin, T. Unger, Johanna I. Busch, 2016, Human molecular genetics.